drugset
drugset / Trial / NCT05004415

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

NCT05004415 ↗

Phase 1 Completed 6 enrolled Atea Pharmaceuticals, Inc. Hoffmann-La Roche · collab
NaSingle-groupOpen-labelTreatment

Summary

Mass balance study of AT-527 in Healthy Male Subjects.

Timeline

Start
2021-07-28
Primary completion
2021-08-12
Completion
2021-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemnifosbuvir Other / unclassified 550 mg —

Indications

No indication recorded.